Latest Breaking News On - Reneep tannenbaum - Page 1 : comparemela.com

ANI Pharmaceuticals : Appoints Experienced Commercial Leader, Renee P Tannenbaum, Pharm D , MBA, to Board of Directors - Form 8-K

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors - Dr. Tannenbaum s successful track record in driving. | March 24, 2022

United statesLisam wilsonReneep tannenbaumPatrickd walshBoards of zogenix incSharps compliance incAni pharmaceuticals appoints experienced commercial leaderSite communications incBoard advisor to aerami therapeutics incUniversity of connecticutCompany incBristol myers squibbPharmaceuticals incExchanges commissionElan pharmaceuticals incCardiff oncology inc

Zogenix : Amendment to Annual Report (Form 10-K/A)

10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM . | March 7, 2022

United statesUnited kingdomRedwood cityResearch triangle parkNorth carolinaSan diegoSyracuse universityDistrict of columbiaSan franciscoUniversity of southern californiaNew jerseyNew yorkUniversity of arizonaRutgers universityStanford universityDana farber cancer institute

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHeinz josef lenzActa oncologicaReneep tannenbaumDanielh ahnMani mohindruAmy jobeJoyce allaireAfsaneh barziManishr sharmaKatherinel ruffnerJamese levineMark erlanderVicki kelemenCardiff oncology incPdac program

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates

Cardiff Oncology Announces the Appointment of Two New Independent Members to its Board of Directors

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical.

United statesReneep tannenbaumThomas adamsGary jacobMark erlanderMani mohindruSharps compliance incZogenix incCuris incUniversity of connecticutCompany incCara therapeutics incBristol myers squibbCerexis incPharmaceuticals incHalozyme inc